HPR116 The Impact of Policy Measures to Increase the Uptake of Biosimilar Medicines in Belgium: A Nationwide Interrupted Time Series Analysis

Belgium has experienced a malfunctioning off-patent biologicals market since the entry of the first biosimilar more than a decade ago. Therefore, the Belgian government has taken several measures to increase the uptake of biosimilars in past years. However, no formal evaluation of the impact of these measures has been made yet. This study aimed to investigate the impact of the implemented measures.